PMA supplement
P240021 S001: Atellica IM Total PSA II (tPSAII)
FDA PMA supplement · Normal 180 Day Track · Siemens Healthcare Diagnostics, Inc.
Key facts
| Original PMA | P240021 |
|---|---|
| Supplement number | S001 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | Atellica IM Total PSA II (tPSAII) |
| Generic name | Total, prostate specific antigen (noncomplexed & complexed) for detection of prostate cancer |
| Applicant | Siemens Healthcare Diagnostics, Inc. |
| Product code | MTF |
| Received date | Feb 27, 2026 |
| Decision date | Aug 26, 2026 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: